ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial ResultsEmily K. Slotkin, William D. Tap, Filemon S. Dela Cruz et al.|JCO oncology advances.|2025Cited by 3